Endometrial Regenerative Cells (ERC) are universal donor adult-derived stem cells with the potential for providing clinical benefit in engineered cell-based therapies for conditions such as cancer, inflammation, and a number of orphan diseases. ERC are derived from the endometrium and are isolated through non-invasive methods.
When combined with Intrexon’s suite of integrated technologies, including UltraVector®
gene engineering and expression control enabled by the RheoSwitch Therapeutic System®
platform, engineered ERC have the potential to be employed as genetically modified vehicles for controlled delivery of therapeutic molecules. These compelling technologies will be further developed for utilization by existing and future collaborators.
Read more about Endometrial Regenerative Cells in the Scientific Literature